Literature DB >> 7272272

Catalytically active monomer and dimer forms of rat liver carbamoyl-phosphate synthetase.

C J Lusty.   

Abstract

Purified carbamoyl-phosphate synthetase of rat liver is shown to exist in a state of rapid, reversible monomer-dimer equilibrium. The allosteric activator N-acetyl-L-glutamate displaces the equilibrium toward monomer formation. This effect is observed over a range of initial protein concentrations of 0.02-5 mg/mL. Measurements of Stokes radii by analytical gel chromatography indicate that at concentrations less than 0.1 mg/mL at 25 degrees C in the presence of all the substrates the enzyme exists as a monomer of 160000 molecular weight. A gel chromatographic method was developed to identify the active form of carbamoyl-phosphate synthetase. On the basis of analysis of the ADP boundary formed during gel chromatography, the monomer is established to be catalytically active. Active enzyme centrifugation studies confirm that the monomer is a reactive species and suggest that the dimer also functions catalytically. Under the conditions of the usual enzyme assay, carbamoyl-phosphate synthetase is mainly in the monomer form. Activation by acetylglutamate can occur at the level of the monomer and is not coupled to dissociation since the enzyme dissociates at low concentrations even in the absence of acetylglutamate. The stoichiometry of the association is observed directly in the electron microscope. The dimensions of the negatively stained particles of the enzyme in the presence or absence of substrates correspond to monomers and dimers, assuming the molecule to be a prolate ellipse. The number of monomers observed in the presence of substrate represents 86% of the total number of enzyme molecules. The average molecular weight calculated from the numbers of particles seen in negatively stained specimens of carbamoyl-phosphate synthetase is 182000. Electron microscope studies provide independent evidence for monomer--dimer interactions and show that under the conditions examined the enzyme is mainly in the monomer form.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7272272     DOI: 10.1021/bi00516a001

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Disruption of the aldolase A tetramer into catalytically active monomers.

Authors:  P T Beernink; D R Tolan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

2.  Identification of cysteine residues in carbamoyl-phosphate synthase I with reactivity enhanced by N-acetyl-L-glutamate.

Authors:  K Geschwill; L Lumper
Journal:  Biochem J       Date:  1989-06-01       Impact factor: 3.857

3.  Activation of carbamoyl phosphate synthetase by cryoprotectants.

Authors:  V Rubio; H G Britton; S Grisolía
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

4.  Kinetic properties of carbamoyl-phosphate synthase (ammonia) and ornithine carbamoyltransferase in permeabilized mitochondria.

Authors:  N S Cohen; C W Cheung; E Sijuwade; L Raijman
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

5.  Role of Cys-1327 and Cys-1337 in redox sensitivity and allosteric monitoring in human carbamoyl phosphate synthetase.

Authors:  Emily J Hart; Susan G Powers-Lee
Journal:  J Biol Chem       Date:  2008-12-23       Impact factor: 5.157

6.  Subunit interface mutants of rabbit muscle aldolase form active dimers.

Authors:  P T Beernink; D R Tolan
Journal:  Protein Sci       Date:  1994-09       Impact factor: 6.725

Review 7.  N-acetylglutamate and its changing role through evolution.

Authors:  Ljubica Caldovic; Mendel Tuchman
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

8.  Structure of human carbamoyl phosphate synthetase: deciphering the on/off switch of human ureagenesis.

Authors:  Sergio de Cima; Luis M Polo; Carmen Díez-Fernández; Ana I Martínez; Javier Cervera; Ignacio Fita; Vicente Rubio
Journal:  Sci Rep       Date:  2015-11-23       Impact factor: 4.379

Review 9.  Deciphering CAD: Structure and function of a mega-enzymatic pyrimidine factory in health and disease.

Authors:  Francisco Del Caño-Ochoa; Santiago Ramón-Maiques
Journal:  Protein Sci       Date:  2021-07-22       Impact factor: 6.725

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.